Related Experiment Video

Updated: Aug 9, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 28, 2010

Increased interleukin 4 (IL-4) receptor expression and IL-4-induced decrease in IL-12 production by Langerhans cells

Heidrun Moll1, Anabel Scharner, Eckhart Kämpgen

  • 1Institute for Molecular Biology of Infectious Diseases, University of Würzburg, Germany. h.moll@mail.uni-wuerzburg.de

Infection and Immunity
|February 21, 2002
PubMed

Insights

Infection with Leishmania major increases interleukin-4 (IL-4) receptor expression on Langerhans cells (LC) in susceptible mice, potentially driving Th2 cell development and susceptibility.

Area of Science:

  • Immunology
  • Cell Biology
  • Parasitology

Background:

  • Langerhans cells (LC) are crucial for initiating T-cell responses to Leishmania major.
  • Cytokines regulate LC function during parasitic infections.
  • Understanding LC cytokine receptor modulation is key to deciphering host-parasite interactions.

Purpose of the Study:

  • To investigate how Leishmania major infection affects cytokine receptor expression on Langerhans cells.
  • To determine the role of interleukin-4 (IL-4) receptor modulation in Leishmania infection susceptibility.

Main Methods:

  • Infection of Langerhans cells with Leishmania major.
  • Analysis of cytokine receptor expression (specifically IL-4 receptor) on infected LC.
  • Assessment of IL-12 production by LC following IL-4 treatment.

Main Results:

  • Interleukin-4 (IL-4) receptor expression was upregulated on infected LC from susceptible mice, but not resistant mice.
  • IL-4 treatment significantly reduced lipopolysaccharide-induced IL-12 production in infected LC from susceptible mice.
  • Modulation of IL-4 receptor and IL-12 production suggests a role in Th2 cell differentiation.

Conclusions:

  • Leishmania major infection alters IL-4 receptor expression on Langerhans cells in a manner dependent on host susceptibility.
  • These changes may promote the development of T-helper 2 (Th2) cells, contributing to susceptibility to Leishmania infection.
  • Targeting these pathways could offer new strategies for managing Leishmania infections.

More Related Videos

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...